Funded Tech Companies

GluBio Therapeutics

Wondering who backed GluBio Therapeutics? Lilly Asia Ventures, Qiming Ventures and Kaitai Capital joined the equity holders in this medical devices company.

Company Overview

Company Name
GluBio Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
Room 810 8th Floor Hemao Building No. 1116 Xingsha South Xin
Hangzhou Zhejiang, Undisclosed
China
Phone
Undisclosed
Email Address
Not Recorded

Company Background Information

Overview
GluBio Therapeutics focuses on molecular glue-targeted protein degradation and provides a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary library of highly active molecules.
Profile
GluBio Therapeutics LinkedIn Company Profile
Social Media
GluBio Therapeutics Company Twitter Account
Company News
GluBio Therapeutics News
Facebook
GluBio Therapeutics on Facebook
YouTube
GluBio Therapeutics on YouTube
Last Transaction
8/1/2022

Financing History

Date
Type
Amount
Venture Equity
$22,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Gang Lu
  Gang Lu LinkedIn Profile  Gang Lu Twitter Account  Gang Lu News  Gang Lu on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Glu Mobile | GlucoLight

 

Share this article

 


About Our VC Deals Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary